Through the new Cervera 2023 call, CDTI will grant grants of up to 90% of the total approved budget.

‍

Objective of the 2023 call

Strengthen the innovation capabilities by contracting R&D activities to knowledge-generating centers or collaborating with them for the development of R&D projects.

‍

Beneficiaries

SMEs and MIDCAPS.

‍

Type of aid

The Cervera 2023 call will grant partially repayable loans of up to 90% of the total budget approved by CDTI, with the following characteristics:

• Interest rate: Fixed. 1-year Euribor (fixed at the time of approval of the aid).

* If the R&D project is co-financed with community funds, the interest rate will only apply to the refundable tranche of the aid.

• Return period: 10 or 15 years. ‍
• Amortization: Biannual. ‍
• Advance payment: 35% of the aid with a limit of 250,000€, without the need for additional guarantees.

‍

The non-refundable tranche may reach up to 33%, calculated on 75% of the budget. The beneficiary company may request the reasoned report once the loan agreement with the CDTI has been formalized.

‍

Main requirements

• Projects must have a minimum fundable budget of 175,000€ and a duration of between 12 and 36 months.
• Projects may have one or more technical milestones, whose duration should be between 9 and 18 months.
• Knowledge centers must have a minimum participation of 10% of the total approved budget.
• Projects must be developed in a limited group of technological areas (Cervera* priority technologies).

*Cervera's priority technologies are defined as:

• Advanced materials
• Circular economy
• Energy transition
• Smart manufacturing
• Technologies for health
• Safe and healthy food chain
• Deep Learning and Artificial Intelligence
• Advanced mobile networks
• Intelligent transport
• Information protection
• Quantum computing.

‍

Fundable projects

Projects of research and business development of an applied nature for the creation or significant improvement of a productive process, product or service. Projects may include industrial research and experimental development activities and must demonstrate a differential technological aspect over existing technologies in the market.

‍

Financiable expenses

• Personnel expenses- Instrument and material costs
• Contract research costs
• Knowledge and acquired patents
• Consulting and equivalent services (excluding those associated with the project request)
• Additional overhead costs
• Other expenses derived from the project

External collaborations may not exceed 65% of the eligible budget in general. In projects in the pharmaceutical sector, these expenses may reach up to 80% of the eligible budget.

‍

Criteria for evaluating applications

At the technical level:

• Plan for commercial exploitation of the project
• Project Technology and Innovation
• Capacity of the company in relation to the project
• Socio-economic impact assessment, gender perspective and sustainability

At the financial level:

• Analysis of the consideration of a company in crisis
• Economic-financial and risk analysis
• Economic-financial analysis of the project
• Economic-financial adaptation of the company to the activities carried out by the project.

‍

Deadline for submitting applications

The Cervera 2023 call for grants will remain open throughout the year.